We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Explains how commissioners and health professionals can use data and analysis for decisions about cardiovascular services and interventions.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
You may need to tell DVLA if you've had heart failure - download the form to let them know
This is a systematic review and meta-analysis
How to use a cost effectiveness analysis to evaluate your digital health product.
Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart, to evaluate blood flow and aid in the diagnosis or assessment of...
How to use a cost utility analysis to evaluate your digital health product.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
You may need to send DVLA a form if you've had a heart attack (myocardial infarction) or heart, cardiac or coronary angioplasty.
Projects granted during 2016 that have a primary purpose of translational applied research - human cardiovascular disorders.
Find out about the long-term effects some people can have after having COVID-19.
Check if you need to tell DVLA about a health or medical condition, how to report medical conditions to DVLA
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
This guide explains how impacts on noise should be incorporated into a cost benefit analysis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).